日韩精品久久无码中文字幕,色欲av无码一区二区三区,少妇无码一区二区三区,精品久久久久国产免费

加入收藏 | 設(shè)為首頁 | 聯(lián)系我們

產(chǎn)品搜索

產(chǎn)品分類

聯(lián)系我們

聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com

產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73192SLC34A2-ROS1 G2032R/BaF3

SLC34A2-ROS1 G2032R/BaF3
名稱 SLC34A2-ROS1 G2032R/BaF3
型號 CBP73192
報價
特點 SLC34A2-ROS1 [G2032R]/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO
  • 詳細(xì)內(nèi)容
CBP73192
I. Introduction

Cell Line Name:

SLC34A2-ROS1 [G2032R]/BaF3

Host Cell:

Ba/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative


II.Background

Approximately 2% of lung tumors harbor ROS1 fusions (Bergethon et al. 2012). Like ALK fusions, ROS1 fusions are more commonly found in light smokers (<10 pack years) and/or never-smokers. ROS1 fusions are also associated with younger age and adenocarcinomas (Bergethon et al. 2012).

In preclinical models, ROS1 fusions are associated with sensitivity to tyrosine kinase inhibitors that have 'off-target' activity against ROS1, such as crizotinib (Bergethon et al. 2012; Davies et al. 2012). In addition, two patients—a previously treated metastatic NSCLC patient and a 65-year-old never smoker NSCLC patient—with tumors harboring ROS1 fusions have had partial responses to crizotinib (Bergethon et al. 2012; Davies et al. 2012). In an expansion cohort of a phase I study, 50 patients with ROS1-positive NSCLC demonstrated a 72% response rate and 19.2-month median progression-free survival interval when treated with crizotinib (Ou et al. 2013; Shaw et al. 2014). In a European case study, 32 ROS1-positive NSCLC cases treated with crizotinib were retrospectively reviewed, and an 80% response rate and a 9.1-month median progression-free survival interval was calculated in this cohort (Mazières et al. 2015).

Several different ROS1 rearrangements have been described in NSCLC. These include SLC34A2-ROS1, CD74-ROS1, EZR-ROS1, TPM3-ROS1, and SDC4-ROS1 (Figure 1; Davies et al. 2012; Rikova et al. 2007; Takeuchi et al. 2012). Clinically, the presence of a ROS1 rearrangement is detected by fluorescence in situ hybridization (FISH) with a ROS1 breakapart probe. FISH testing is not able to discern which particular ROS1 fusion is found in a clinical sample.

ROS1 rearrangements are non-overlapping with other oncogenic mutations found in NSCLC (e.g., EGFR mutations, KRAS mutations, ALK fusions, etc.; Bergethon et al. 2012).


III. Representative Data

1. WB of SLC34A2-ROS1 [G2032R]/BaF3expression

CBP73192 WB.png


Figure 1. Protein Expression of ROS1 detected by antibody


2.Sanger Sequencing of SLC34A2-ROS1 Fusion and G2032R mutation

CBP73192 sanger-1.png

Figure 2. SLC34A2-ROS1 Fusion

CBP73192 sanger2.png

Figure 3. ROS1 p.G2032R


3. Anti-proliferation assay

CBP73192 fig.png

Figure 4. Anti-proliferation assay of two reference compounds on the SLC34A2-ROS1 [G2032R]/BaF3 Stable Cell Line.



如果你對CBP73192SLC34A2-ROS1 G2032R/BaF3感興趣,想了解更詳細(xì)的產(chǎn)品信息,填寫下表直接與廠家聯(lián)系:


留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說明:

  • 驗證碼:

    請輸入計算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7

化工儀器網(wǎng)

推薦收藏該企業(yè)網(wǎng)站
蜜桃麻豆WWW久久囤产精品| 大乳丰满人妻中文字幕日本| 精品人妻一区二区三区四区在线| chinese国产avvideoxxxx实拍| 国产精品欧美成人片| 交换年轻夫妇hd中文字幕3d| 免费在线黄色电影| 美少年高潮h跪趴扩张调教喷水| 男人又粗又大又猛又硬| www.五月天| 亚洲人成亚洲人成在线观看| 性色做爰片在线观看ww| 国模小黎自慰gogo人体| 蜜桃色欲av久久无码精品| 新狼窝色AV性久久久久久| 一区二区乱子伦在线播放| 色欲久久综合亚洲精品蜜桃| 精品人妻系列无码人妻免费视频| 国产免费又色又爽粗视频| 美女被c到爽哭视频网站| 色综合久久久久综合体桃花网| 精品一区| 中文字幕日韩欧美一区二区三区| 久热国产精品视频一区二区三区| 国产麻豆剧传媒精品国产av| 白少洁第1一40章免费阅读| 无码人妻久久一区二区三区蜜桃| 天干夜天干天天天爽视频| 国产精品久久久久AAAA| 国产美女在线精品免费观看网址| 女子初尝黑人巨嗷嗷叫| 小箩莉末发育娇小性色xxxx| 成免费crm在线看系统| 国产一区二区波多野结衣| 真人做爰高潮全过程毛片| 国产50部艳色禁片无码| 色欲av无码一区二区三区| 诱人的奶头bd在线观看| 玉米地诱子偷伦初尝云雨孽欲| 欧美精品乱码99久久蜜桃| 亚州av综合色区无码一区|